LONDON, February 10, 2016 /PRNewswire/ --
A Worldwide Clinical Trials expert will present at Evidence EU 2016, which will be held at Victoria Park Plaza in London, 24-25 February 2016. Worldwide will host an informative seminar on technology and future advances for late phase research on Wednesday, 24 Feb at 15:00. The seminar, led by Lorna Graham, associate director of project management at Worldwide, will focus on how to leverage technology to keep up with new regulations and standards in late phase research.
“Evidence EU provides an ideal platform for experts from across the industry to share knowledge and best practice,” said Graham. “I look forward to leading the discussion on how technology can aid with discovering hidden safety issues, and the impact and benefits of new treatment regimes by exploring long-term follow-up options for patients, including the wider population implications.”
Evidence EU is the largest pharmaceutical industry event that focuses on real world evidence to support drug development, prove market value and enhance patient care. Worldwide will exhibit at stand #15, where attendees can learn more about how the company partners with sponsors to effectively advance drug development and help secure patient outcomes.
To schedule an appointment with a Worldwide representative at Evidence EU, go to http://www.worldwide.com/events. For information about Evidence EU, visit http://www.healthnetworkcommunications.com/conference/evidence-eu/ .
About Worldwide Clinical Trials
Worldwide Clinical Trials provides full-service drug development services to the pharmaceutical and biotechnology industries from Early Phase and Bioanalytical Sciences through Phase II and III trials to Peri-Approval studies. We believe successful drug development strategically balances science, medicine, operations and commercial intelligence. We approach every Phase I-IV drug development program as unique. Our mission is to foster the development of life changing medicines by integrating innovative methodology, rigorous science and efficient technology. For more information, visit http://www.Worldwide.com.
SOURCE Worldwide Clinical Trials
